Systemic bevacizumab for pediatric patients with aggressive recurrent respiratory papillomatosis: One single‐center experience of eight patients

Systemic bevacizumab for pediatric patients with aggressive recurrent respiratory papillomatosis: One single‐center experience of eight patients

Abstract Recurrent respiratory papillomatosis (RRP) is a human papilloma virus (HPV)‐driven benign neoplasm, affecting larynx, trachea, and even lung, leading to voice disorders, airway obstruction, and postobstructive pneumonia. Several case reports have documented the promising efficacy of intrave...

Full description

Bibliographic Details
Main Authors: Zengjun Liu, Yang Xiao, Jing Xu, Mengyao Liu, Mingyong Han, Wenyu Hu, Dongyuan Zhu
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:Laryngoscope Investigative Otolaryngology
Subjects:
bevacizumab
efficacy
pediatrics
recurrent respiratory papillomatosis
safety
Online Access:https://doi.org/10.1002/lio2.1013

Internet

https://doi.org/10.1002/lio2.1013

Similar Items